vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and UNITED FIRE GROUP INC (UFCS). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $365.8M, roughly 1.3× UNITED FIRE GROUP INC). On growth, UNITED FIRE GROUP INC posted the faster year-over-year revenue change (9.8% vs -1.7%). Over the past eight quarters, UNITED FIRE GROUP INC's revenue compounded faster (11.2% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

The United Fruit Company was an American multinational corporation that traded in tropical fruit grown on Latin American plantations and sold in the United States and Europe. The company was formed in 1899 from the merger of the Boston Fruit Company with Minor C. Keith's banana-trading enterprises. It flourished in the early and mid-20th century, and it came to control vast territories and transportation networks in Central America, the Caribbean coast of Colombia, and the West Indies. Althou...

MD vs UFCS — Head-to-Head

Bigger by revenue
MD
MD
1.3× larger
MD
$493.8M
$365.8M
UFCS
Growing faster (revenue YoY)
UFCS
UFCS
+11.5% gap
UFCS
9.8%
-1.7%
MD
Faster 2-yr revenue CAGR
UFCS
UFCS
Annualised
UFCS
11.2%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
UFCS
UFCS
Revenue
$493.8M
$365.8M
Net Profit
$33.7M
Gross Margin
Operating Margin
9.9%
13.2%
Net Margin
6.8%
Revenue YoY
-1.7%
9.8%
Net Profit YoY
10.5%
EPS (diluted)
$0.40
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
UFCS
UFCS
Q4 25
$493.8M
$365.8M
Q3 25
$492.9M
$354.0M
Q2 25
$468.8M
$335.5M
Q1 25
$458.4M
$331.1M
Q4 24
$502.4M
$333.2M
Q3 24
$511.2M
$323.0M
Q2 24
$504.3M
$301.2M
Q1 24
$495.1M
$296.0M
Net Profit
MD
MD
UFCS
UFCS
Q4 25
$33.7M
Q3 25
$71.7M
$39.2M
Q2 25
$39.3M
$22.9M
Q1 25
$20.7M
$17.7M
Q4 24
$30.5M
Q3 24
$19.4M
$19.7M
Q2 24
$-153.0M
$-2.7M
Q1 24
$4.0M
$13.5M
Operating Margin
MD
MD
UFCS
UFCS
Q4 25
9.9%
13.2%
Q3 25
13.8%
13.7%
Q2 25
12.8%
8.7%
Q1 25
7.0%
6.6%
Q4 24
7.8%
11.9%
Q3 24
6.6%
7.7%
Q2 24
-31.3%
-1.3%
Q1 24
3.2%
5.5%
Net Margin
MD
MD
UFCS
UFCS
Q4 25
6.8%
Q3 25
14.5%
11.1%
Q2 25
8.4%
6.8%
Q1 25
4.5%
5.3%
Q4 24
6.1%
Q3 24
3.8%
6.1%
Q2 24
-30.3%
-0.9%
Q1 24
0.8%
4.6%
EPS (diluted)
MD
MD
UFCS
UFCS
Q4 25
$0.40
$1.45
Q3 25
$0.84
$1.49
Q2 25
$0.46
$0.87
Q1 25
$0.24
$0.67
Q4 24
$0.37
$1.22
Q3 24
$0.23
$0.76
Q2 24
$-1.84
$-0.11
Q1 24
$0.05
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
UFCS
UFCS
Cash + ST InvestmentsLiquidity on hand
$375.2M
$156.3M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
$941.2M
Total Assets
$2.2B
$3.8B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
UFCS
UFCS
Q4 25
$375.2M
$156.3M
Q3 25
$340.1M
$233.7M
Q2 25
$224.7M
$202.1M
Q1 25
$99.0M
$183.7M
Q4 24
$229.9M
$200.9M
Q3 24
$103.8M
$197.4M
Q2 24
$19.4M
$153.4M
Q1 24
$8.0M
$217.8M
Total Debt
MD
MD
UFCS
UFCS
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
UFCS
UFCS
Q4 25
$865.9M
$941.2M
Q3 25
$890.7M
$898.7M
Q2 25
$833.8M
$845.7M
Q1 25
$789.2M
$817.7M
Q4 24
$764.9M
$781.5M
Q3 24
$732.5M
$785.8M
Q2 24
$706.5M
$726.6M
Q1 24
$856.2M
$736.8M
Total Assets
MD
MD
UFCS
UFCS
Q4 25
$2.2B
$3.8B
Q3 25
$2.2B
$3.8B
Q2 25
$2.1B
$3.7B
Q1 25
$2.0B
$3.5B
Q4 24
$2.2B
$3.5B
Q3 24
$2.1B
$3.5B
Q2 24
$2.0B
$3.4B
Q1 24
$2.2B
$3.2B
Debt / Equity
MD
MD
UFCS
UFCS
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
UFCS
UFCS
Operating Cash FlowLast quarter
$114.1M
$269.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
UFCS
UFCS
Q4 25
$114.1M
$269.7M
Q3 25
$137.3M
$60.8M
Q2 25
$137.2M
$53.4M
Q1 25
$-117.5M
$35.7M
Q4 24
$133.0M
$340.3M
Q3 24
$91.8M
$56.5M
Q2 24
$107.0M
$91.3M
Q1 24
$-125.2M
$36.2M
Cash Conversion
MD
MD
UFCS
UFCS
Q4 25
3.39×
Q3 25
1.91×
1.55×
Q2 25
3.49×
2.33×
Q1 25
-5.66×
2.02×
Q4 24
4.36×
Q3 24
4.72×
2.86×
Q2 24
Q1 24
-31.03×
2.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

UFCS
UFCS

Segment breakdown not available.

Related Comparisons